QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) Business Wire Nawigacja wpisu Beat AML Master Trial Expands Precision Medicine Options for Patients With AML: Ashley Yocum, PhD – AJMC Florida man back home after receiving second liver transplant at Chicago’s Northwestern Medicine – CBS News
